Search for comprehensive disease, drugs and company information from one convenient location with the all-new Pharma360.
Updated daily using the power of the entire Pharma Intelligence suite of products, Pharma360 immediately delivers critical intelligence from Trialtrove, Pharmaprojects, Datamonitor Healthcare, Biomedtracker, Pink Sheet, Scrip, and Medtech Insight for your full drugs, disease and companies overview – all from one single, simple search.
Save time, increase your efficiency, and capture all the vital information you need in just one search, with the Pharma360.
LOGIN: A single login page gives you instant access to all your Pharma Intelligence accounts and data. Simply log in and start searching.
SEARCH: Enter your disease, drugs & company search in a simple-to-use, clean interface that auto-suggests terms you may be looking for as you type. Pharma360 conducts a seamless, dynamic search across all your Pharma Intelligence products and returns results instantly capturing essential information on trials, drugs, and more, all from a single entry point.
ANALYZE: Gain instant insight through dynamic dashboards that allow you to easily:
CUSTOMIZE: Create a personalized view of the Pharma landscape, tailored to your business needs, through customizable dashboards. Quickly and easily uncover key industry insights through interactive, visual data available to export to enhance your presentations.
Easily search company, disease, and drug content across the Pharma Intelligence portfolio.
This single sign-on, simple search interface empowers you to easily gather and store the data that matters to you.
Informa Pharma Intelligence conducted a study to measure the time savings of the Pharma360 tool.
The results are now available, read the blog today.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: